These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease. Guo Q; Ping L; Dammer EB; Yin L; Xu K; Shantaraman A; Fox EJ; Golde TE; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT Res Sq; 2024 Feb; ():. PubMed ID: 38464223 [TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids. Korecka M; Shaw LM J Neurochem; 2021 Oct; 159(2):211-233. PubMed ID: 34244999 [TBL] [Abstract][Full Text] [Related]
14. CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease. Lizama BN; Williams C; North HA; Pandey K; Duong D; Di Caro V; Mecca AP; Blennow K; Zetterberg H; Levey AI; Grundman M; van Dyck CH; Caggiano AO; Seyfried NT; Hamby ME Alzheimers Dement; 2024 Oct; 20(10):6860-6880. PubMed ID: 39166791 [TBL] [Abstract][Full Text] [Related]
16. Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum. Paciotti S; Wojdała AL; Bellomo G; Toja A; Chipi E; Piersma SR; Pham TV; Gaetani L; Jimenez CR; Parnetti L; Chiasserini D Alzheimers Res Ther; 2023 Jul; 15(1):124. PubMed ID: 37454217 [TBL] [Abstract][Full Text] [Related]
17. An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease. Lizama BN; North HA; Pandey K; Williams C; Duong D; Cho E; Di Caro V; Ping L; Blennow K; Zetterberg H; Lah J; Levey AI; Grundman M; Caggiano AO; Seyfried NT; Hamby ME Neurobiol Dis; 2024 Sep; 199():106575. PubMed ID: 38914170 [TBL] [Abstract][Full Text] [Related]
18. Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid. Wojtas AM; Dammer EB; Guo Q; Ping L; Shantaraman A; Duong DM; Yin L; Fox EJ; Seifar F; Lee EB; Johnson ECB; Lah JJ; Levey AI; Levites Y; Rangaraju S; Golde TE; Seyfried NT medRxiv; 2024 Jan; ():. PubMed ID: 38260316 [TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive. Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform. Agnello L; Giglio RV; Del Ben F; Piccoli T; Colletti T; Scazzone C; Lo Sasso B; Ciaccio AM; Gambino CM; Salemi G; Ciaccio M Sci Rep; 2024 Jul; 14(1):16084. PubMed ID: 38992063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]